Innosuisse

In this expert interview conducted by Swiss Venture Club, @Fabian Käser, an innovation mentor for Innosuisse, shares his insights from working with SMEs. He supports them in structuring ideas, finding research partners, and submitting projects. Read the full interview: https://lnkd.in/es7uYSaf

Innosuisse's Taftie presidency in 2024 is coming to an end. Innosuisse had the opportunity to organise five events under this year's theme ‘Expanding the Horizon’.💪 Annalise Eggimann, Chairperson of Taftie and former CEO of Innosuisse, takes stock in an interview. She says: "Innosuisse’s international stature has increased significantly thanks to its presidency of Taftie". 👏 Read the full interview: https://lnkd.in/etNwYkNQ More about Taftie: https://lnkd.in/eAhTGttp A big THANK YOU to the whole Taftie-Presidency Team: Annika Nussbaum Fabian Mende Claudia Wyss Alexa Nodari Ophélia Egger Elisa Despina Maret Johanne Stettler Eliane Kersten Lukas Krienbuehl

How to set a legal framework for open innovation❔   In open innovation, creating a safe space for people to share knowledge and ideas is vital for successful co-creation. With Quentin L. Adler and Daniel Kraus from the Université de Neuchâtel, Joelle Tosetti from the Innovation Booster Microtech developed an intellectual property framework that enables a trust-building setting with clear rules for participation and collaboration.   Innovation Booster help you boost radical innovation through open innovation and user tests: https://lnkd.in/dsSun5j8   Follow the #swissinnovationbooster and subscribe to the group: https://lnkd.in/ejuUb3Ki

16 innovative projects have been approved for funding under the 2024 call of the Swiss-Polish cooperation programme The calls are implemented in cooperation with the The National Centre for Research and Development and financed by the Swiss contribution to selected EU member states. The 2025 call will be announced next January. The following Swiss research institutions are among the 16 projects of the 2024 call: Berner Fachhochschule BFH | OST – Ostschweizer Fachhochschule | University of Zurich | Universitätsspital Zürich | CSEM | EPFL | ETH Zürich | Empa Learn more about the projects : https://lnkd.in/gcrqSnGU Swiss Agency for Development and Cooperation Embassy of Switzerland in Poland

Congratulations to the new BRIDGE Programme fellows! 🤩

The Federal Council re-elected today André Kudelski as president, and Sergio P. Ermotti, Aude Pugin and Anna Valente as members to the Innosuisse Board for the 2025–28 term of office. Kristina Shea, Professor for Engineering Design and Computing at ETH Zurich, was elected as a new board member. The expertise of Professor Kristina Shea in the fields of engineering design and computing is an ideal complement to the skills of the re-elected members. Applied digitalisation is indeed of key significance for SMEs. Welcome to Innosuisse Kristina! Edouard Bugnion and Marco Illy will step down from the Innosuisse Board at the end of the year. Innosuisse would like to thank them for their valuable and long-standing commitment to Swiss innovation funding. https://lnkd.in/eJhpJ_hR

Are radical and disruptive innovation the same❔ Equating disruptive with radical innovation is mixing up two ways of categorising innovation. Learn from radical innovation expert Jean-Philippe Hagmann about the difference between the two and the strategic potential behind disruption.💡   The Innovation Booster help you boost radical innovation through open innovation and user tests: https://lnkd.in/dsSun5j8   Follow the #swissinnovationbooster and subscribe to the group: https://lnkd.in/ejuUb3Ki

🚀 Pioneering a transformative breakthrough in disease treatment, HAYA Therapeutics aims to reshape patient care by harnessing the potential of Dark Genome-derived RNAs to reprogram diseased cells back to a healthy state. 🧬 With its groundbreaking approach, the company has captured the attention of pharmaceutical giant Eli Lilly and Company. 🌟💊 Riding this wave of momentum, HAYA Therapeutics is poised to elevate its cutting-edge technology onto the global stage, revolutionising the treatment of rare, common and chronic diseases. Read more: https://lnkd.in/djAJ-Rx9 With: Samir Ounzain and Daniel Blessing, PhD

Innovation projects drive revenue and job creation! The latest research by KOF Konjunkturforschungsstelle der ETH Zürich at ETH Zürich investigates the causal effect of the Innosuisse funding for joint innovation projects between companies and universities as research partners. Did you know that companies involved in innovation projects create significantly 𝐦𝐨𝐫𝐞 𝐣𝐨𝐛𝐬 𝐚𝐧𝐝 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞 𝐬𝐭𝐫𝐨𝐧𝐠𝐞𝐫 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 than those without support from Innosuisse? Learn more about the scientific study: https://lnkd.in/gxFckUZS

🚀 The Swiss Startup Radar 2023 shows resilience in a challenging market. 🌟 The latest edition of the report delivers fresh, data-driven insights into how Swiss start-ups are navigating the global funding downturn. Read the key points of the report on Startupticker.ch https://lnkd.in/e_FhHzmv